Today on Drug Discovery & Development
Gene therapy yields 100x vision average improvement, with a few reaching 10,000x
Imagine going from near-total blindness to seeing the world in a whole new light – literally. That’s the reality for some participants in a recent gene therapy trial for LCA1, where vision improvements ranged from a 100-fold increase to a 10,000-fold jump. LCA1 (Leber Congenital Amaurosis 1) is a type of Leber Congenital Amaurosis that…
Leveraging HF/UX/ID Services to Optimize the Design of Combination Devices for Arthritic Hands
By Dr. Bryce G Rutter, Head of Consulting Services Arthritis changes how people grasp and manipulate an object, reducing the functional capacity of many adults worldwide; it is one of the most significant considerations when designing combination devices. Ergonomic Combination Devices for Arthritis Patients Arthritis significantly impacts how people grasp and manipulate objects, reducing their…
Drug Discovery and Development See More >
The roadmap to effective AI-driven drug development
Generative artificial intelligence (GAI) has captivated the world, and for good reason. Platforms like ChatGPT have demonstrated capabilities that gave the general public a deeper understanding of AI’s capabilities. AI, too, is showing potential in drug discovery. From designing novel drug molecules to predicting protein structures, AI is offering a new path forward, potentially accelerating…
Sponsored Content See More >
Leveraging HF/UX/ID Services to Optimize the Design of Combination Devices for Arthritic HandsBy Dr. Bryce G Rutter, Head of Consulting Services Arthritis changes how people grasp and manipulate an object, reducing the…
Ask the Expert: Navigating the New FDA Rules on Laboratory Developed Tests (LDTs)The U.S. FDA released a final rule to regulate laboratory developed tests (LDTs) on May 6, 2024, making it clear…
How tailored qPCR assays can unlock microbiome and precision medicine potential Sponsored by Diversigen, Inc. Quantitative Polymerase Chain Reaction (qPCR) — also known as real-time PCR — is a molecular…
Innovations in Baculovirus–Insect Cell Expression SystemsThe baculovirus–insect cell expression system—insect cells used in conjunction with the baculovirus expression vector system (BEVS)—remains a crucial technology for…
Patient Training is Broken – And Everyone is Paying For ItNoble International is working with Pharma and Specialty Pharmacy to fix the problem. The report, “The Current Paradigm for Biologic…
Noble Leads with its User-Centered Design StrategyBy Tim McLeroy, Executive Director of Marketing and Patient Services, Noble International At Noble, the patient journey drives everything we…
Using Real-World Data to Address COVID-19By Cheryl Reifsnyder, PhD As a leading provider of data and advanced analytics, Veradigm understands the critical role real-world data…
Discovering Antigen-specific Monoclonal Antibodies using Single B Cell ScreeningIntroduction Since the approval of Orthoclone OKT3 in 1986, more than 100 monoclonal antibodies (mAbs) have been approved by the…
A new way to access scientific papers?Losing university access doesn’t mean losing access to articles anymore By DeepDyve Digital Library Team Many researchers are surprised to…
These are not fireworks: The objective truthBy Jan Barghaan, Strategic Marketing Manager Life Science, Olympus Europa No, not fireworks — it’s actually a single colony of…
AI technology automates tedious cell culture work and analysesBy Joanna Hawryluk, PhD, Product Manager, Olympus Life Science Since the early 20th century, cell culture has been considered the…
What is Human AB serum?By Trevor Smith, MS MBA, Product Manager, Immune Cells Human AB Serum is a staple in the biological research field,…
Genomics/Proteomics See More >
![A display of DNA sequencing output from an automated ABI 373 sequencer. [National Human Genome Research Institute (NHGRI)]](https://www.drugdiscoverytrends.com/wp-content/uploads/2024/06/51187236177_b7b566a401_k-368x238.jpg)
Helix and Recursion join forces in quest to crack the AI-driven drug discovery code
The UK Biobank, with genetic data on half a million individuals, set a benchmark for scale in medical research. It contains whole genome sequencing data for all 500,000 participants, making it the world’s largest genetic project to date. A recent collaboration between the San Diego–headquartered clinico-genomics company Helix and the Salt Lake City–based biotech Recursion…
Athos Therapeutics chooses Vultr’s private cloud to power AI drug discovery engine
Deep Genomics announces key hires, expands operations in Cambridge, Mass.
Study combines biomimetic AI, digital twins and multiomics to unveil potential genetic drivers of endometriosis
Unleashing a new frontier: The power of germline clinico-genomic data to drive therapeutic development
Infectious Disease See More >
Moderna and Pfizer win approval for KP.2 vaccine as KP.3 variants account for about half of current cases
The FDA has approved Moderna’s and Pfizer’s updated COVID-19 vaccines targeting the KP.2 variant, an offshoot of the Omicron strain that was dominant in the U.S. in May 2024. More recently, KP.3 variants are gaining ground. As of August 20, 2024, CDC Nowcast projections estimate KP.3.1.1 accounts for approximately 37% of new COVID-19 cases in…
Moderna’s single-dose mRNA RSV vaccine, mRESVIA, gains FDA approval for adults 60+
Best-selling pharmaceuticals of 2023 reveal a shift in pharma landscape
Longevity biotech gaining momentum as demographic shifts drive demand for healthy aging
Public vs. private: Who’s leading the charge in H5N1 preparedness?
Oncology See More >
Earli and Accenture partner in quest to turn cancer against itself
Redwood City, California–based Earli is, in many ways, a quintessential Silicon Valley startup. As is often the case, there’s not only a Stanford connection but a grand ambition. The company is developing a “synthetic biopsy” platform that aims to detect cancer at its earliest stages by programming cancer cells to reveal themselves and even self-destruct.…
AI drug discovery space consolidates with $688M Recursion and Exscientia merger
Breakthrough FDA approval for first solid tumor cell therapy signals new era for cancer treatment
Preparing for the golden age of small molecule oncology drugs
